Features of inflammatory biomarkers in patients with occupational COPD and cardiovascular comorbidity

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, with over 30% of these patients dying from cardiovascular diseases. Objective: to study the pathophysiological links between echocardiography, spirometry indicators, and inflammatory biomarkers in patients with various clinical phenotypes of occupational COPD with cardiovascular comorbidity. Material and methods. The study included 111 patients with occupational COPD and cardiovascular comorbidity. Based on spirometry results, patients were divided into 4 groups (clinical phenotypes). Clinical examinations, echocardiography, and serum concentrations of troponin I, endothelin-1 (E-1), endothelial synthase (ES), hyaluronic acid (HA), and myoglobin were performed. Results. The concentrations of troponin I, myoglobin, and E-1 were normal in all groups. HA concentration was highest among phenotype “E” patients (p = 0.0008). ES concentration in phenotype “E” was more than 2.5 times higher compared to other groups (p = 0.0022). Myoglobin concentration positively correlated with left ventricular myocardium thickness, ES, eosinophil levels, and coronary heart disease (p < 0.05), while ES concentration correlated positively with hypertension. HA concentration negatively correlated with spirometry and echocardiography indicators and positively correlated with eosinophil levels and exacerbations (p < 0.05). Conclusion. Further research is needed to identify biomarkers reflecting the risk of exacerbations in cardiovascular comorbidities in patients with occupational COPD

1. Zafari Z., Li S., Eakin M.N., Bellanger M., Reed R.M. Projecting long-term health and economic burden of COPD in the United States. Chest. 2021;159(4):1400–1410. DOI: 10.1016/j.chest.2020.09.255. PMID: 33011203.

2. Lisspers K., Larsson K., Janson C., Ställberg B., Tsiligianni I., Gutzwiller F.S. et al. Gender diff erences among Swedish COPD patients: results from the ARCTIC, a real-world retrospective cohort study. NPJ Prim. Care Respir. Med. 2019;29(1):45. DOI: 10.1038/s41533-019-0157-3

3. Drapkina O.M., Kontsevaya A.V., Mukaneeva D.K., Smirnova M.I., Antsiferova A.A., Lukyanov M.M. et al. Forecast of the socioeconomic burden of COPD in the Russian Federation in 2022. Pulmonologiya. 2022;32(4):507–516. (In Russian)]. DOI: 10.18093/0869-0189-2022-32-4-507-516

4. Panachevа L.A., Shpagina L.A. Chronic obstructive pulmonary disease among workers exposed to in-dustrial aerosols: literature review. Perm Medical Journal. 2020;37(6):61–70. (In Russian)]. DOI: 10.17816/pmj37661-70

5. Shen E., Lee J.S., Mularski R.A., Crawford P., Go A.S., Sung S.H.et al. COPD Comorbidity Profi les and 2-Year Trajectory of Acute and Postacute Care Use. Chest. 2021;159(6):2233–2243. DOI: 10.1016/j.chest.2021.01.020

6. Dolbin S.S., Adasheva T.V., Samorukova E.I., Malyavin A.G., Li V.V., Vysotskaya N.V., Zadionchenko V.S. Stratifi cation of cardiovascular risk in patients with chronic obstructive pulmonary disease. Therapy. 2020;6(5):69–77. (In Russian)]. DOI: 10.18565/therapy.2020.5.69-77

7. Umnyagina I.A., Blinova T.V., Strahova L.A., Troshin V.V., Fedotov V.D. Oxidized low-density lipoproteins as indicators of the developmnet of chronic cardiovascular insuffi ciency in patients with chronic obstructive pulmonary disease of occupational etiology. The Journal of Atherosclerosis and Dyslipidemias. 2019;4(37):46–53 (In Russian)]. DOI: 10.34687/2219-8202.JAD.2019.03.0005

8. Milutina M.Y., Fedotov V.D., Makarova E.V., Menkov N.V, Plastinina S.S., Lyubavina N.A. Indicators of vascular wall stiff ness in patients with chronic obstructive pulmonary disease in combination with hypertension. Klinicheskaya meditsina. 2019;97(10):692–697. (In Russian)]. DOI: 10.34651/0023-2149-2019-97-10-692-697

9. Makarova E., Milutina M., Fedotov V., Menkov N., Lyubavina N., Plastinina S. Arterial stiff ness in patients with chronic obstructive pulmonary disease combined with arterial hypertension. European Respiratory Journal. 2020;56:2983; DOI: 10.1183/13993003.congress-2020.2983

10. Fedotova O.O, Fedotov V.D. Features of the systemic infl ammatory response in patients with chronic respiratory pathology of professional etiology. In the collection: hygiene, ecology and health risks in modern conditions. Proceedings of the interregional scientifi c and practical conference of young scientists and specialists. Ed. by V.F. Spirina. 2017:229–233. (In Russian)].

11. Fedotov V.D., Lavrenyuk N.A., Dobrotina I.S. et al. Clinical and laboratory phenotypes of occupational chronic obstructive pulmonary disease. The Bulletin of Contemporary Clinical Medicine. 2023;16(1):69–79. (In Russian)]. DOI: 10.20969/VSKM.2023.16(1).69-79.

12. Fedotov V.D., Khlystov A.C., Blinova T.V., Strakhova L.A., Lavrenyuk N.A., Dobrotina I.S. Hyaluronic acid as a predictor of exacerbation of occupational chronic obstructive pulmonary disease. Pulmonologiya. 2022;32(6):862–868. (In Russian)]. DOI: 10.18093/0869-0189-2022-32-6-862-868

13. Furuta G.T., Atkins F.D., Lee N.A., Lee J.J. Changing roles of eosinophils in health and disease. Ann. Allergy Asthma Immunol. 2014;113(1):3–8. DOI: 10.1016/j.anai.2014.04.002

14. Singh D., Kolsum U., Brightling C.E., Locantore N., Agusti A., Tal-Singer R. ECLIPSE investigators. Eosinophilic infl ammation in COPD: prevalence and clinical characteristics. Eu.r Respir. J. 2014;44(6):1697–700. DOI: 10.1183/09031936.00162414. Epub 2014 Oct 16. PMID: 25323230.

15. David B., Bafadhel M., Koenderman L., De Soyza A. Eosinophilic infl ammation in COPD: from an infl ammatory marker to a treatable trait. Thorax. 2021;76(2):188–195. DOI: 10.1136/thoraxjnl-2020-215167

16. Barnes P.J. Infl ammatory endotypes in COPD. Allergy. 2019;74(7):1249–1256. DOI: 10.1111/all.13760

17. Khamitov R.F., Vizel A.A., Zhestkov A.V., Bogdanova Ju.V., Galushina I.A., Zvereva E.V. et al. Inhaled corticosteroids and chronic obstructive pulmonary disease: a review of the concept. The Bulletin of Contemporary Clinical Medicine. 2020;13(3):58–63. (In Russian)]. DOI: 10.20969/VSKM.2020.13(3).58-63

18. Fedotov V.D., Blinova T.V., Strakhova L.A., Lavrenyuk N.A., Umnyagina I.A., Dobrotina I.S. Hyaluronic acid as a marker for remodeling of bronchopulmonary system in patients with occupational pulmonary pathology. Pulmonologiya. 2019;29(6):679– 684. (In Russian)]. DOI: 10.18093/0869-0189-2019-29-6-679-684

19. Samolyuk M.O., Grigorieva N.Yu., Kontorschikova K.N., Shakhova K.A. Features of oxidative stress and endothelial dysfunction in patients with arterial hypertension in combination with chronic obstructive pulmonary disease. Medical almanac.2020;4(65):38–46. (In Russian)].

20. Barton M., Yanagisawa M. Endothelin: 30 Years From Discovery to Therapy. Hypertension. 2019;74(6):1232–1265. DOI: 10.1161/HYPERTENSIONAHA.119.12105

21. Yan F., Pidayi M., Xia Y., et al. The prognosis value of C-reactive protein and endothelin-1 in chronic obstructive pulmonary disease patients with pulmonary artery pressure. Pak. J. Pharm. Sci. 2019;32(4):1697–1701.

22. Csoma B., Bikov A., Nagy L., Tóth B., Tábi T., Szűcs G., Komlósi Z.I., Müller V., Losonczy G., Lázár Z. Dysregulation of the endothelial nitric oxide pathway is associated with airway infl ammation in COPD. Respir. Res. 2019;20(1):156. DOI: 10.1186/s12931-019-1133-8

23. Polverino F., Celli B.R., Owen C.A. COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series). Pulm. Circ. 2018;8(1):204–589. DOI: 10.1177/2045894018758528

24. Witting P.K., Douglas D.J., Mauk A.G. Reaction of human myoglobin and nitric oxide. Heme iron or protein sulfhydryl (s) nitrosation dependence on the absence or presence of oxygen. J. Biol. Chem. 2001;276(6):3991–8. DOI: 10.1074/jbc.M005758200

25. Waschki B., Alter P., Zeller T., Magnussen C., Neumann J.T., Twerenbold R., Sinning C., Herr C., Kahnert K., Fähndrich S., Blankenberg S., Rabe K.F., Welte T., Jörres R.A., Vogelmeier C.F., Bals R., Watz H; German COSYCONET Cohort. High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study. Eur. Respir. J. 2020;55(2):1901314. DOI: 10.1183/13993003.01314-2019

26. Nilsson U., Vanfl eteren LEGW. Troponin as a biomarker for mortality in stable COPD. Eur. Respir. J. 2020;55(2):1902447. DOI: 10.1183/13993003.02447-2019

27. GOLD. Global strategy for prevention, diagnostic and management of COPD: 2023 Report. [ Electronic resource]. URL: https:// goldcopd.org/wp-content/uploads/2023/03/GOLD-2023-ver-1.3-17Feb2023_WMV.pdf. Accessed January 2024.

28. Chuchalin A.G., Avdeev S.N., Aisanov Z.R., Belevskiy A.S., Leshchenko I.V., Ovcharenko S.I., Shmelev E.I. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. Pulmonologiya. 2022;32(3):356–392. (In Russian)]. DOI: 10.18093/0869-0189-2022-32-3-356-392

29. Fedotov V.D., Milutina M.J. Clinical features of occupational chronic obstructive bronchitis. Russian Journal of Occupational Health and Industrial Ecology. 2019;(9):790–791. (In Russian)]. DOI/10.31089/1026-9428-2019-59-9-790-791

30. Occupational respiratory diseases. National guidelines. Ed. By N.F. Izmerova, A.G. Chuchalina. Moskva. «GEOTAR-Media». 2015:792. (in Russian)].

31. Baksheev V.I., Kolomoec N.M., Tursunova G.F.. Clinical signifi cance of echocardiographic examination methods of the right heart. Klinicheskaya medicina. 2006;84(10):16–23. (In Russian)].

32. Method for determining the direction of the course of chronic occupational bronchitis. Fedotov V.D., Umnyagina I.A., Blinova T.V., Strakhova L.A., Troshin V.V., Belousko N.I., Kournikova A.A., Oshevensky L.V. Patent for invention 2733866 C1, 07.10.2020. Application № 2020105085 ot 03.02.2020. In Russian].

33. Garantziotis S., Brezina M., Castelnuovo P., Drago L. The role of hyaluronan in the pathobiology and treatment of respiratory disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2016;310(9):L785–95. DOI: 10.1152/ajplung.00168.2015

34. Tornling G., Eklund A., Engström-Laurent A. et al. Hyaluronic acid in bronchoalveolar lavage in rats exposed to quartz. Br. J. Ind. Med. 1987;44(7):443–445. DOI:10.1136/oem.44.7.443

35. Rønnow S.R., Sand J.M.B., Langholm L.L., Manon-Jensen T., Karsdal M.A., Tal-Singer R., Miller B.E., Vestbo J., Leeming D.J. Type IV collagen turnover is predictive of mortality in COPD: a comparison to fi brinogen in a prospective analysis of the ECLIPSE cohort. Respir. Res. 2019;20(1):63. DOI: 10.1186/s12931-019-1026-x

36. Blinova, T. V. Strahova L.A. Serum endothelial synthase in professional bronchopulmonary pathology and its relationship with nitric oxide metabolites. Problems of hygienic safety and management of risk factors for public health: Scientifi c works. Nizhny Novgorod. Printing house OOO Stimul-ST. 2015:65–68. (In Russian)].

37. Frolov A., Pochinka I.G., Fedotov V., Korotkikh A.V., Borodin E.A. Infl uence of COPD on hospital outcomes of PCI in patients with ACS. Respirology. 2023;28(S1). DOI: 10.1111/resp.14433

38. Fedotov V.D., Frolov A.A., Kouzova G.N., Protasova N.V., Zamotina T.S., Musaev E.S. et al. Prevalence of chronic airways diseases in patients with acute coronary syndrome. Sovremennye problemy nauki i obrazovaniya. 2021;4. (in Russian)]. [Electronic resource]. URL: https://science-education.ru/ru/article/view?id=30983